{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2026:ALT543H5WIRJDX3KCDDADCNX4I","short_pith_number":"pith:ALT543H5","schema_version":"1.0","canonical_sha256":"02e7de6cfdb22291df6a10c60189b7e2314b215f831e12ff9de3a8219cb9df26","source":{"kind":"arxiv","id":"2606.23275","version":1},"attestation_state":"computed","paper":{"title":"A Bayesian Phase I/II basket design with robust information borrowing to identify subtrial-specific optimal biological doses","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Haiyan Zheng, Pavel Mozgunov, Zhi Cao","submitted_at":"2026-06-22T12:52:58Z","abstract_excerpt":"The objective of modern early oncology dose-finding is to identify an optimal biological dose (OBD), rather than simply the maximum tolerated dose. In basket trials, the dose-toxicity and dose-efficacy relationships may differ across biomarker or disease-defined subtrials, so a single common dose from pooled analysis may be suboptimal. We propose a flexible exchangeability-non-exchangeability (EXNEX) dose finding design (DF-EXNEX design) for subtrial-specific OBD selection in basket phase I/II trials with binary toxicity and continuous efficacy endpoints. Patient toxicity is modelled by a mono"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2606.23275","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.AP","submitted_at":"2026-06-22T12:52:58Z","cross_cats_sorted":[],"title_canon_sha256":"ddfa01cf1c87cfba10825b9abbf9bd170fba70f3874c59059eac38f8204fb538","abstract_canon_sha256":"6cebcec66db6a2f4dd9e42c48f24b1ae35cd0e9ec512c62726c991bb06f04049"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-06-23T03:14:15.505884Z","signature_b64":"Be7VyQOua+sG3+p9hOhU7hLD8E6J3UpyvNi5XyI2Htz6x7MheZjW54MUtZ2uCxnMHyBX+G8RhTwrg81NHjPGCQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"02e7de6cfdb22291df6a10c60189b7e2314b215f831e12ff9de3a8219cb9df26","last_reissued_at":"2026-06-23T03:14:15.505341Z","signature_status":"signed_v1","first_computed_at":"2026-06-23T03:14:15.505341Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"A Bayesian Phase I/II basket design with robust information borrowing to identify subtrial-specific optimal biological doses","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Haiyan Zheng, Pavel Mozgunov, Zhi Cao","submitted_at":"2026-06-22T12:52:58Z","abstract_excerpt":"The objective of modern early oncology dose-finding is to identify an optimal biological dose (OBD), rather than simply the maximum tolerated dose. In basket trials, the dose-toxicity and dose-efficacy relationships may differ across biomarker or disease-defined subtrials, so a single common dose from pooled analysis may be suboptimal. We propose a flexible exchangeability-non-exchangeability (EXNEX) dose finding design (DF-EXNEX design) for subtrial-specific OBD selection in basket phase I/II trials with binary toxicity and continuous efficacy endpoints. Patient toxicity is modelled by a mono"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2606.23275","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2606.23275/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2606.23275","created_at":"2026-06-23T03:14:15.505398+00:00"},{"alias_kind":"arxiv_version","alias_value":"2606.23275v1","created_at":"2026-06-23T03:14:15.505398+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2606.23275","created_at":"2026-06-23T03:14:15.505398+00:00"},{"alias_kind":"pith_short_12","alias_value":"ALT543H5WIRJ","created_at":"2026-06-23T03:14:15.505398+00:00"},{"alias_kind":"pith_short_16","alias_value":"ALT543H5WIRJDX3K","created_at":"2026-06-23T03:14:15.505398+00:00"},{"alias_kind":"pith_short_8","alias_value":"ALT543H5","created_at":"2026-06-23T03:14:15.505398+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I","json":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I.json","graph_json":"https://pith.science/api/pith-number/ALT543H5WIRJDX3KCDDADCNX4I/graph.json","events_json":"https://pith.science/api/pith-number/ALT543H5WIRJDX3KCDDADCNX4I/events.json","paper":"https://pith.science/paper/ALT543H5"},"agent_actions":{"view_html":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I","download_json":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I.json","view_paper":"https://pith.science/paper/ALT543H5","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2606.23275&json=true","fetch_graph":"https://pith.science/api/pith-number/ALT543H5WIRJDX3KCDDADCNX4I/graph.json","fetch_events":"https://pith.science/api/pith-number/ALT543H5WIRJDX3KCDDADCNX4I/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I/action/timestamp_anchor","attest_storage":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I/action/storage_attestation","attest_author":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I/action/author_attestation","sign_citation":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I/action/citation_signature","submit_replication":"https://pith.science/pith/ALT543H5WIRJDX3KCDDADCNX4I/action/replication_record"}},"created_at":"2026-06-23T03:14:15.505398+00:00","updated_at":"2026-06-23T03:14:15.505398+00:00"}